Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Bodymedia

Research Leaders

6 sponsors active, led by Amsterdam UMC, location VUmc

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06625801Recruiting

IVUS CHIP UPP Registry

NCT07380217Not ApplicableRecruiting

Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures

NCT01394705Not ApplicableCompletedPrimary

FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study

Showing all 3 trials

Research Network

Common Treatments

  • Bodymedia1
  • Ivus1
  • Mechanical Circulatory Support With The Pulsecath Ivac2l Device1

Active Sponsors

  • Amsterdam UMC, location VUmc1
  • Cardialysis BV1
  • ECRI bv1
  • Pulsecath BV.1
  • Boston Scientific Corporation1

Top Investigators

Related Conditions

  • Highrisk Pci1
  • Coronary Artery Disease1
  • Complex Coronary Artery Disease1

Activity Timeline